106-120 of 123
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
CME/CESecondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
Mario Cozzolino, MD, PhD
Jan T. Kielstein, MD, FASN, FERA
David Jayne, MD
Annette Bruchfeld, MD, PhD
Jürgen Floege, MD
Jonathan Barratt, MD, PhD
David Jayne, MD
Case Management Strategies for Patients with ADPKD – Part 2
CME/CECase Management Strategies for Patients with ADPKD – Part 2
Frederic Rahbari-Oskoui, MD, MSc
Case Management Strategies for Patients with ADPKD – Part 1
CME/CECase Management Strategies for Patients with ADPKD – Part 1
Fouad T. Chebib, MD
Pranav S. Garimella, MD
Kristen Nowak, PhD
- advertisement
Imaging in the Diagnosis and Management of ADPKD
CME/CEImaging in the Diagnosis and Management of ADPKD
Theodora A. Potretzke, MD
Fouad T. Chebib, MD
Neera Dahl, MD, PhD
Craig E. Gordon, MD
Frederic Rahbari-Oskoui, MD, MSc
Melanie Betz, MS, RD, CSR, CSG
Investigator Interview: Volume Progression in ADPKD
CME/CEInvestigator Interview: Volume Progression in ADPKD
Arlene B. Chapman, MD
Investigator Interview: Treating Rapidly Progressing Patients with ADPKD
CME/CEInvestigator Interview: Treating Rapidly Progressing Patients with ADPKD
- advertisement
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 4: Emerging Therapies
CME/CEOptimizing the Care and Quality of Life for Patients with ADPKD – Part 4: Emerging Therapies
Arlene B. Chapman, MD
Michel Chonchol, MD
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 3: Management
CME/CEOptimizing the Care and Quality of Life for Patients with ADPKD – Part 3: Management
Michel Chonchol, MD
Frederic Rahbari-Oskoui, MD, MSc
